Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Dorkin JR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Smekalova EM; Beam Therapeutics, Cambridge, MA 02142, USA., Martinez MG; INSERM U1052, Cancer Research Center of Lyon, CNRS UMR 5286, 69008 Lyon, France.; University of Lyon, UMR_S1052, UCBL, 69008 Lyon, France.; Hepatology Institute of Lyon, 69008 Lyon, France., Combe E; INSERM U1052, Cancer Research Center of Lyon, CNRS UMR 5286, 69008 Lyon, France.; University of Lyon, UMR_S1052, UCBL, 69008 Lyon, France.; Hepatology Institute of Lyon, 69008 Lyon, France., Kumar A; INSERM U1052, Cancer Research Center of Lyon, CNRS UMR 5286, 69008 Lyon, France.; University of Lyon, UMR_S1052, UCBL, 69008 Lyon, France.; Hepatology Institute of Lyon, 69008 Lyon, France., Dejene S; Beam Therapeutics, Cambridge, MA 02142, USA., Leboeuf D; Beam Therapeutics, Cambridge, MA 02142, USA., Chen CY; Beam Therapeutics, Cambridge, MA 02142, USA., Dorkin JR; Beam Therapeutics, Cambridge, MA 02142, USA., Shuang LS; Beam Therapeutics, Cambridge, MA 02142, USA., Kieft S; Beam Therapeutics, Cambridge, MA 02142, USA., Young L; Beam Therapeutics, Cambridge, MA 02142, USA., Barrera LA; Beam Therapeutics, Cambridge, MA 02142, USA., Packer MS; Beam Therapeutics, Cambridge, MA 02142, USA., Ciaramella G; Beam Therapeutics, Cambridge, MA 02142, USA., Testoni B; INSERM U1052, Cancer Research Center of Lyon, CNRS UMR 5286, 69008 Lyon, France.; University of Lyon, UMR_S1052, UCBL, 69008 Lyon, France.; Hepatology Institute of Lyon, 69008 Lyon, France., Gregoire F; Beam Therapeutics, Cambridge, MA 02142, USA., Zoulim F; INSERM U1052, Cancer Research Center of Lyon, CNRS UMR 5286, 69008 Lyon, France.; University of Lyon, UMR_S1052, UCBL, 69008 Lyon, France.; Hepatology Institute of Lyon, 69008 Lyon, France.; Hepatology Department, Hospices Civils de Lyon (HCL), 69004 Lyon, France.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Dec 27; Vol. 35 (1), pp. 102112. Date of Electronic Publication: 2023 Dec 27 (Print Publication: 2024).
Autor:
Kauffman KJ; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Oberli MA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Dorkin JR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Hurtado JE; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Kaczmarek JC; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Bhadani S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Wyckoff J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139., Jaklenec A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Anderson DG; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139. Electronic address: dgander@mit.edu.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2018 Mar 02; Vol. 10, pp. 55-63. Date of Electronic Publication: 2017 Nov 21.
Autor:
Fenton OS; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Kauffman KJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Kaczmarek JC; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., McClellan RL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Jhunjhunwala S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Tibbitt MW; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Zeng MD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Appel EA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Dorkin JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Mir FF; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Yang JH; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Oberli MA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Heartlein MW; Shire Pharmaceuticals, Lexington, MA, 02421, USA., DeRosa F; Shire Pharmaceuticals, Lexington, MA, 02421, USA., Langer R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Anderson DG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Publikováno v:
Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2017 Sep; Vol. 29 (33). Date of Electronic Publication: 2017 Jul 06.
Autor:
Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG; Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States., Langer R; Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States., Blankschtein D
Publikováno v:
Nano letters [Nano Lett] 2017 Mar 08; Vol. 17 (3), pp. 1326-1335. Date of Electronic Publication: 2016 Dec 05.
Autor:
Luo X; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. dong.525@osu.edu., Wang W; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dgander@mit.edu and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA., Dorkin JR; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Veiseh O; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dgander@mit.edu and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Chang PH; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dgander@mit.edu and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA., Abutbul-Ionita I; Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute, Haifa 32000, Israel., Danino D; Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute, Haifa 32000, Israel., Langer R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dgander@mit.edu and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Anderson DG; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dgander@mit.edu and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Dong Y; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. dong.525@osu.edu and Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA and The Center for Clinical and Translational Science, The Ohio State University, Columbus, OH 43210, USA and The Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Publikováno v:
Biomaterials science [Biomater Sci] 2016 Dec 20; Vol. 5 (1), pp. 38-40.
Autor:
DeRosa F; Shire Pharmaceuticals, Lexington, MA, USA., Guild B; Shire Pharmaceuticals, Lexington, MA, USA., Karve S; Shire Pharmaceuticals, Lexington, MA, USA., Smith L; Shire Pharmaceuticals, Lexington, MA, USA., Love K; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Dorkin JR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Kauffman KJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Zhang J; Shire Pharmaceuticals, Lexington, MA, USA., Yahalom B; Biomedical Research Models, Inc., Worcester, MA, USA., Anderson DG; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Division of Health Sciences & Technology, Cambridge, MA, USA.; Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Heartlein MW; Shire Pharmaceuticals, Lexington, MA, USA.
Publikováno v:
Gene therapy [Gene Ther] 2016 Oct; Vol. 23 (10), pp. 699-707. Date of Electronic Publication: 2016 Jun 30.
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery.
Autor:
Fenton OS; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Kauffman KJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., McClellan RL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Appel EA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Dorkin JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Tibbitt MW; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Heartlein MW; Shire Pharmaceuticals, Lexington, MA, 02421, USA., DeRosa F; Shire Pharmaceuticals, Lexington, MA, 02421, USA., Langer R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Anderson DG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Publikováno v:
Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2016 Apr 20; Vol. 28 (15), pp. 2939-43. Date of Electronic Publication: 2016 Feb 18.
Autor:
Yin H; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Song CQ; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Dorkin JR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Zhu LJ; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Li Y; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai, P.R. China., Wu Q; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Park A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Yang J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Suresh S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bizhanova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Gupta A; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Bolukbasi MF; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Walsh S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bogorad RL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Gao G; Gene Therapy Center, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Weng Z; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Dong Y; College of Pharmacy, the Ohio State University, Columbus, Ohio, USA., Koteliansky V; Skolkovo Institute of Science and Technology, Skolkovo, Russia.; Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, Russia., Wolfe SA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Langer R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Harvard-MIT Division of Health Sciences &Technology, Cambridge, Massachusetts, USA.; Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Xue W; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Anderson DG; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Harvard-MIT Division of Health Sciences &Technology, Cambridge, Massachusetts, USA.; Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2016 Mar; Vol. 34 (3), pp. 328-33. Date of Electronic Publication: 2016 Feb 01.
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo.
Autor:
Dong Y; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Dorkin JR, Wang W; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Chang PH; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Webber MJ; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Tang BC; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Yang J; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States., Abutbul-Ionita I; Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute , Haifa 32000, Israel., Danino D; Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute , Haifa 32000, Israel., DeRosa F; Shire , 300 Shire Way, Lexington, Massachusetts 02421, United States., Heartlein M; Shire , 300 Shire Way, Lexington, Massachusetts 02421, United States., Langer R; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States., Anderson DG; David H. Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, §Department of Biology, and ∥Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.; Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School , Boston, Massachusetts 02115, United States.
Publikováno v:
Nano letters [Nano Lett] 2016 Feb 10; Vol. 16 (2), pp. 842-8. Date of Electronic Publication: 2016 Jan 13.